Related Experiment Video
Updated: Jun 7, 2025

07:50
A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
15.9K
MultiADE: A Multi-domain benchmark for Adverse Drug Event extraction
Xiang Dai1, Sarvnaz Karimi1, Abeed Sarker2
1CSIRO Data61, Sydney, Australia.
Journal of Biomedical Informatics
|November 13, 2024
Summary
Current models struggle with domain generalization for adverse drug event extraction across diverse text types. Further research in domain adaptation is needed for effective real-world deployment in pharmacovigilance.
Area of Science:
- Natural Language Processing
- Pharmacovigilance
- Machine Learning
Background:
- Active adverse event surveillance relies on extracting Adverse Drug Events (ADEs) from various data sources.
- Existing datasets and tasks primarily focus on single text types, limiting model generalizability.
- Domain generalization for ADE extraction across diverse text (e.g., scientific literature, social media) remains under-explored.
Purpose of the Study:
- To assess the current capabilities of machine learning models in extracting ADEs across different text domains.
- To develop a comprehensive benchmark for evaluating domain generalization in ADE extraction.
- To investigate the feasibility of a single ADE extraction model effective across various text types.
Main Methods:
- Construction of the MultiADE benchmark, incorporating existing datasets and the new CADECv2 dataset.
- CADECv2 extends CADEC with annotations for online posts covering a wider range of drugs.
- Annotation of the new dataset by human annotators following detailed guidelines.
Main Results:
- Trained models exhibit imperfect generalization across different text domains, hindering deployment.
- Intermediate transfer learning shows promise but requires further investigation into domain adaptation methods.
- Cost-effective methods for selecting useful training instances are crucial for improving domain adaptation.
Conclusions:
- Current ADE extraction models are not yet suitable for processing diverse text types without domain-specific adaptation.
- Domain adaptation techniques, particularly efficient instance selection, are essential for improving model performance.
- The MultiADE benchmark and CADECv2 dataset are publicly available to advance research in information extraction for pharmacovigilance.
Related Concept Videos
Pharmacovigilance
774
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
774
Combined Effects of Drugs: Antagonism
8.3K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.3K
Drug Concentrations: Measurements
332
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma...
Plasma...
332
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
Drug Discovery: Overview
7.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.5K

